Cargando…
Molecular-targeted therapy for advanced anaplastic thyroid cancer combined with nutritional support
Management of anaplastic thyroid cancer (ATC) is often difficult because of its aggressive characteristics. Molecular-targeted therapy was recently introduced as an alternative therapeutic strategy for ATC; lenvatinib is a molecular-targeted agent that is currently indicated only in Japan for the tr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fujita Medical Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766233/ https://www.ncbi.nlm.nih.gov/pubmed/35111497 http://dx.doi.org/10.20407/fmj.2018-003 |